Eagle Health Investments LP increased its stake in Cano Health, Inc. (NYSE:CANO – Free Report) by 1,847.9% in the first quarter, according to the company’s latest Form 13F filing with the SEC. The company acquired an additional 4,070,617 shares during the quarter, making it a holding of 4,290,901 shares. Cano Health represents approximately 0.8% of Eagle Health Investments LP’s investment portfolio, making the stock his 21st largest holding in the company. Eagle Health Investments LP owned approximately 0.81% of Cano Health, valued at $3,905,000, at the end of the most recent quarter.
Other hedge funds are also buying and selling shares of the company. Mercer Global Advisors Inc. ADV acquired new shares of Cano Health worth approximately $27,000 during the fourth quarter. Ground Swell Capital LLC acquired new shares of Cano Health worth approximately $27,000 in the first quarter. Apollon Wealth Management LLC increased its stake in Kano Health by 78.9% during the fourth quarter. Apollon Wealth Management LLC purchased an additional 9,860 shares last quarter and now owns 22,360 shares in the company, valued at $31,000. GSA Capital Partners LLP increased its stake in Cano Health by 64.8% in the fourth quarter. GSA Capital Partners LLP purchased an additional 9,224 shares last quarter and now owns 23,456 shares of the company, valued at $32,000. Finally, Mirae Asset Global Investments Co. Ltd. increased his stake in Cano Health by 49.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. purchased an additional 12,159 shares last quarter and now owns 36,687 shares worth $33,000. 35.99% of the shares are held by institutional investors.
Kano Health Trading up 18.2%
NYSE:CANO shares rose $0.06 to $0.37 in Friday noon trading. The company had a trading volume of 18,513,063 shares and an average volume of 8,167,651 shares. The company has a 50-day moving average price of $1.09 and a 200-day moving average price of $1.23. The company has a market capitalization of $196.94 million, a P/E of -0.22 and a beta of 0.01. The company has a debt to equity ratio of 3.95, a current ratio of 0.49 and a quick ratio of 0.49. Kano Health has a one-year low of $0.22 and a one-year high of $9.75.
Wall Street analyst speaks out
Many equity research analysts have been giving their opinions on stock prices lately. In a research note on Friday, August 11, Citigroup downgraded Kano Health’s stock from a “buy” rating to a “neutral” rating and cut the company’s price target to $0.80 from $4.00. Jefferies Financial Group downgraded Kano Health stock to a ‘hold’ rating from ‘buy’ in a research note on Friday, Aug. 11. Finally, Piper Sandler raised his price target on Kano Health stock to $1.00 in a research note on Tuesday, May 16. One research analyst rated the stock as a “sell” and nine rated the stock as a “hold.” Based on MarketBeat.com data, Cano Health has an average rating of “Hold” and a consensus price target of $2.69 for him.
Read the latest stock analysis on CANO
Insider trading at Cano Health
In other Kano Health news, insider Richard Aguilar sold 500,000 shares in the company in a transaction on Monday, June 12. The shares sold at an average price of $1.42, bringing the total transaction value to his $710,000. After the sale closes, the insider owns 1,213,984 shares in the company, valued at approximately $1,723,857.28. The sale was disclosed in documents filed with the Securities and Exchange Commission, which can be accessed on the SEC’s website. In the past 90 days, insiders have sold 959,749 shares of the company, valued at $1,276,925. 16.41% of the shares are owned by corporate insiders.
About CanoHealth
(free report)
Cano Health, Inc provides primary care medical services to members in the United States and Puerto Rico. The company owns and operates medical centers enabled by his CanoPanorama, a platform powered by proprietary population health management technology. It provides medical center providers with a 360-degree view of a member’s girlfriend, providing actionable insights to improve care decisions and member engagement.
Recommended stories
This instant news alert was generated by MarketBeat’s narrative science technology and financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments regarding this story to contact@marketbeat.com.
Listen to this before you consider Cano Health.
MarketBeat tracks Wall Street’s highest-rated, highest-performing research analysts and the stocks they recommend to clients every day. MarketBeat has identified five stocks top analysts are secretly whispering to customers to buy now before the whole market goes viral…and Cano Health wasn’t on the list.
Kano Health currently has a “downgrade” rating among analysts, but high-scoring analysts think these five stocks are better buys.
Click here for 5 brands
Need to expand your 401K or Roth IRA plan? Use these proven investment strategies to increase the monthly retirement income your stock portfolio generates.
Get This Free Report